|
CO-ADMINISTRATION MAY CAUSE SINIFICANT DECREASE IN SERUM LEVELS OF DELAVIRDINE & INDINAVIR. TO AVOID THIS IT SHOULD BE GIVEN 1 HR PRIOR TO DIDANOSINE
|
CYTOCHROME P450 INHIBITORS MAY INHIBIT 25 HYDROXYLATION OF DOXERCALCIFEROL, HENCE FORMATION OF ACTIVE MOITY MAY BE HINDERED
|
DAPOXETINE DOSE IS RESTRICTED TO 30 MG DUE TO POSSIBILITY OF INCREASED SIDE EFFECTS ON COADMINISTRATION
|
DELAVIRDINE, DUE TO INHIBITORY EFFECT ON CYP 450 ENZYME PLASMA CONC. OF OTHER DRUG INCREASES
|
DELAVIRDINE, DUE TO INHIBITORY EFFECT ON CYP 450 ENZYME PLASMA CONC. OF OTHER DRUG INCREASES
|
DELAVIRDINE, DUE TO INHIBITORY EFFECT ON CYP 450 ENZYME PLASMA CONC. OF OTHER DRUG INCREASES
|
DELAVIRDINE, DUE TO INHIBITORY EFFECT ON CYP 450 ENZYME PLASMA CONC. OF OTHER DRUG INCREASES
|
DELAVIRDINE, DUE TO INHIBITORY EFFECT ON CYP 450 ENZYME PLASMA CONC. OF OTHER DRUG INCREASES
|
DELAVIRDINE, DUE TO INHIBITORY EFFECT ON CYP 450 ENZYME PLASMA CONC. OF OTHER DRUG INCREASES
|
DELAVIRDINE, DUE TO INHIBITORY EFFECT ON CYP 450 ENZYME PLASMA CONC. OF OTHER DRUG INCREASES
|
DELAVIRDINE, DUE TO INHIBITORY EFFECT ON CYP 450 ENZYME PLASMA CONC. OF OTHER DRUG INCREASES
|
DELAVIRDINE, DUE TO INHIBITORY EFFECT ON CYP 450 ENZYME PLASMA CONC. OF OTHER DRUG INCREASES
|